2 studies found for:    11496232 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Xolair in Patients With Chronic Sinusitis
Condition: Sinusitis
Intervention: Drug: Anti-IgE antibody omalizumab or placebo
2 Completed
Has Results
Inner-City Anti-IgE Therapy for Asthma
Condition: Asthma
Interventions: Biological: omalizumab;   Biological: omalizumab placebo

Indicates status has not been verified in more than two years